Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1985 Sep;49(3):715–718. doi: 10.1128/iai.49.3.715-718.1985

Vibrio vulnificus resists phagocytosis in the absence of serum opsonins.

M L Tamplin, S Specter, G E Rodrick, H Friedman
PMCID: PMC261253  PMID: 4030101

Abstract

Invasive disease caused by Vibrio vulnificus may result partially from resistance to phagocytic host defense mechanisms. The present studies show that V. vulnificus resists phagocytosis by murine peritoneal macrophages in the absence of serum opsonins and extracellular bacterial products, apparently through the anti-phagocytic properties of the bacterial surface.

Full text

PDF
715

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amako K., Okada K., Miake S. Evidence for the presence of a capsule in Vibrio vulnificus. J Gen Microbiol. 1984 Oct;130(10):2741–2743. doi: 10.1099/00221287-130-10-2741. [DOI] [PubMed] [Google Scholar]
  2. Blake P. A., Merson M. H., Weaver R. E., Hollis D. G., Heublein P. C. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med. 1979 Jan 4;300(1):1–5. doi: 10.1056/NEJM197901043000101. [DOI] [PubMed] [Google Scholar]
  3. Blake P. A., Weaver R. E., Hollis D. G. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol. 1980;34:341–367. doi: 10.1146/annurev.mi.34.100180.002013. [DOI] [PubMed] [Google Scholar]
  4. Bowdre J. H., Poole M. D., Oliver J. D. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun. 1981 Jun;32(3):1193–1199. doi: 10.1128/iai.32.3.1193-1199.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carruthers M. M., Kabat W. J. Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serum. Infect Immun. 1981 May;32(2):964–966. doi: 10.1128/iai.32.2.964-966.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fierer J., Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest. 1979 May;63(5):912–921. doi: 10.1172/JCI109391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grasso R. J., Klein T. W., Benjamin W. R. Inhibition of yeast phagocytosis and cell spreading by glucocorticoids in cultures of resident murine peritoneal macrophages. J Immunopharmacol. 1981;3(2):171–192. doi: 10.3109/08923978109026425. [DOI] [PubMed] [Google Scholar]
  8. Horwitz M. A., Silverstein S. C. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest. 1980 Jan;65(1):82–94. doi: 10.1172/JCI109663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Johnson D. E., Calia F. M., Musher D. M., Goree A. Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans. J Infect Dis. 1984 Sep;150(3):413–418. doi: 10.1093/infdis/150.3.413. [DOI] [PubMed] [Google Scholar]
  10. Kreger A. S., Gray L. D., Testa J. Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera. Infect Immun. 1984 Sep;45(3):537–543. doi: 10.1128/iai.45.3.537-543.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kreger A., DeChatelet L., Shirley P. Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis. J Infect Dis. 1981 Sep;144(3):244–248. doi: 10.1093/infdis/144.3.244. [DOI] [PubMed] [Google Scholar]
  12. Kreger A., Lockwood D. Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect Immun. 1981 Aug;33(2):583–590. doi: 10.1128/iai.33.2.583-590.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liang-Takasaki C. J., Grossman N., Leive L. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen. J Immunol. 1983 Apr;130(4):1867–1870. [PubMed] [Google Scholar]
  14. Liang-Takasaki C. J., Mäkelä P. H., Leive L. Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol. 1982 Mar;128(3):1229–1235. [PubMed] [Google Scholar]
  15. Liang-Takasaki C. J., Saxén H., Mäkelä P. H., Leive L. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun. 1983 Aug;41(2):563–569. doi: 10.1128/iai.41.2.563-569.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pantazis C. G., Kniker W. T. Assessment of blood leukocyte microbial killing by using a new fluorochrome microassay. J Reticuloendothel Soc. 1979 Aug;26(2):155–170. [PubMed] [Google Scholar]
  17. Smith D. L., Rommel F. A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitro. J Immunol Methods. 1977;17(3-4):241–247. doi: 10.1016/0022-1759(77)90106-5. [DOI] [PubMed] [Google Scholar]
  18. Smith G. C., Merkel J. R. Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness. Infect Immun. 1982 Mar;35(3):1155–1156. doi: 10.1128/iai.35.3.1155-1156.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tamplin M. L., Specter S., Rodrick G. E., Friedman H. Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect Immun. 1983 Dec;42(3):1187–1190. doi: 10.1128/iai.42.3.1187-1190.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Testa J., Daniel L. W., Kreger A. S. Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus. Infect Immun. 1984 Aug;45(2):458–463. doi: 10.1128/iai.45.2.458-463.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Valtonen M. V., Plosila M., Valtonen V. V., Mäkelä P. H. Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis. Infect Immun. 1975 Oct;12(4):828–832. doi: 10.1128/iai.12.4.828-832.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Valtonen M. V. Role of phagocytosis in mouse virulence of Salmonella typhimurium recombinants with O antigen 6,7 or 4,12. Infect Immun. 1977 Dec;18(3):574–582. doi: 10.1128/iai.18.3.574-582.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wright A. C., Simpson L. M., Oliver J. D. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun. 1981 Nov;34(2):503–507. doi: 10.1128/iai.34.2.503-507.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yoshida S., Ogawa M., Mizuguchi Y. Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect Immun. 1985 Feb;47(2):446–451. doi: 10.1128/iai.47.2.446-451.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES